ReviewJournal of intensive care2026
Discontinuation of the development of remimazolam for ICU sedation in Japan: background and rationale.
Junichi Saito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it